Serum Bone Biomarkers and Oral/Systemic Bone Loss in Humans
Authors:
- 21 March 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Dental Research
- Vol. 90 (6) , 747-751
Abstract
We recently reported that subantimicrobial-dose doxycycline (SDD) significantly reduced serum bone-resorption biomarkers in subgroups of post-menopausal women. We hypothesize that changes in serum bone biomarkers are associated not only with systemic bone mineral density (BMD) changes, but also with alveolar bone changes over time. One hundred twenty-eight eligible post-menopausal women with periodontitis and systemic osteopenia were randomly assigned to receive SDD or placebo tablets twice daily for two years, adjunctive to periodontal maintenance. Sera were analyzed for bone biomarkers. As expected, two-year changes in a serum bone biomarker were significantly associated with systemic BMD loss at the lumbar spine (osteocalcin, bone-turnover biomarker, p = 0.0002) and femoral neck (osteocalcin p = 0.0025). Two-year changes in serum osteocalcin and serum pyridinoline-crosslink fragment of type I collagen (ICTP; bone-resorption biomarker) were also significantly associated with alveolar bone density loss (p < 0.0001) and alveolar bone height loss (p = 0.0008), respectively. Thus, we have shown that serum bone biomarkers are associated with not only systemic BMD loss, but with alveolar bone loss as well. Clinical Trial Registration Information: Protocol registered at ClinicalTrials.gov, NCT00066027. Abbreviations: bone mineral density (BMD), bone-specific alkaline phosphatase (BSAP), computer-assisted densitometric image analysis (CADIA), confidence interval (CI), deoxypyridinoline-containing degradation fragment of the C-terminal telopeptide region of type I collagen (CTX), coefficient of variation (CV), dual-energy x-ray absorptiometry (DXA), pyridinoline-crosslink-containing degradation fragment of the C-terminal telopeptide region of type I collagen (ICTP), and subantimicrobial-dose doxycycline (SDD).Keywords
This publication has 18 references indexed in Scilit:
- Using tetracyclines to treat osteoporotic/osteopenic bone loss: From the basic science laboratory to the clinicPharmacological Research, 2011
- Teriparatide and Osseous Regeneration in the Oral CavityNew England Journal of Medicine, 2010
- Early changes in biochemical markers of bone turnover and their relationship with bone mineral density changes after 24 months of treatment with teriparatideOsteoporosis International, 2010
- Doxycycline Effects on Serum Bone Biomarkers in Post-menopausal WomenJournal of Dental Research, 2010
- Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and TreatmentJournal of Oral and Maxillofacial Surgery, 2007
- Subantimicrobial dose doxycycline effects on alveolar bone loss in post‐menopausal womenJournal of Clinical Periodontology, 2007
- Destructive Periodontal Disease in Adults 30 Years of Age and Older in the United States, 1988‐1994Journal of Periodontology, 1999
- Computerized Methodology for Detection of Alveolar Crestal Bone Loss From Serial Intraoral RadiographsJournal of Periodontology, 1992
- Extraoral control of geometry for digital subtraction radiographyJournal of Periodontal Research, 1987
- Relationship Between Alveolar Bone Measured by 125I Absorptiometry With Analysis of Standardized Radiographs: 2. Bjorn TechniqueJournal of Periodontology, 1982